Primary vitreoretinal lymphoma (PVRL) is a rare type of non-Hodgkin lymphoma that affects the eyes, specifically the retina and vitreous. It typically presents as blurred vision, floaters, or loss of vision in one or both eyes. PVRL is challenging to diagnose due to its similarity to other eye conditions. Recent advances in cancer research have highlighted the importance of early detection through improved imaging techniques and molecular analysis of vitreous samples. Treatment often involves a combination of chemotherapy, radiation therapy, and intravitreal injections. However, the prognosis remains guarded, with a high risk of recurrence and potential central nervous system involvement. Ongoing research aims to elucidate the underlying mechanisms of PVRL development and identify novel targeted therapies to improve patient outcomes.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States